Catto JW - Search Results

1

Partial ablation versus radical prostatectomy in intermediate-risk prostate cancer: the PART feasibility RCT.

Hamdy FC, Elliott D, le Conte S, Davies LC, Burns RM, Thomson C, Gray R, Wolstenholme J, Donovan JL, Fitzpatrick R, Verrill C, Gleeson F, Singh S, Rosario D, Catto JW, Brewster S, Dudderidge T, Hindley R, Emara A, Sooriakumaran P, Ahmed HU, Leslie TA. Hamdy FC, et al. Among authors: catto jw. Health Technol Assess. 2018 Sep;22(52):1-96. doi: 10.3310/hta22520. Health Technol Assess. 2018. PMID: 30264692 Free PMC article. Clinical Trial.

2

Prostate specific antigen: biology, biochemistry and available commercial assays.

Ward AM, Catto JW, Hamdy FC. Ward AM, et al. Among authors: catto jw. Ann Clin Biochem. 2001 Nov;38(Pt 6):633-51. doi: 10.1258/0004563011901055. Ann Clin Biochem. 2001. PMID: 11732646 Review.

3

Effectiveness and cost-effectiveness of prognostic markers in prostate cancer.

Calvert NW, Morgan AB, Catto JW, Hamdy FC, Akehurst RL, Mouncey P, Paisley S. Calvert NW, et al. Among authors: catto jw. Br J Cancer. 2003 Jan 13;88(1):31-5. doi: 10.1038/sj.bjc.6600630. Br J Cancer. 2003. PMID: 12556955 Free PMC article.

4

Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability.

Catto JW, Xinarianos G, Burton JL, Meuth M, Hamdy FC. Catto JW, et al. Int J Cancer. 2003 Jul 1;105(4):484-90. doi: 10.1002/ijc.11109. Int J Cancer. 2003. PMID: 12712438

5

Genetic instability and transitional cell carcinoma of the bladder.

Catto JW, Meuth M, Hamdy FC. Catto JW, et al. BJU Int. 2004 Jan;93(1):19-24. doi: 10.1111/j.1464-410x.2004.04548.x. BJU Int. 2004. PMID: 14678361 Review.

6

Less is more: artificial intelligence and gene-expression arrays.

Hamdy FC, Catto JW. Hamdy FC, et al. Among authors: catto jw. Lancet. 2004 Dec 4-10;364(9450):2003-4. doi: 10.1016/S0140-6736(04)17528-4. Lancet. 2004. PMID: 15582046 No abstract available.

7

Proteomic analysis of voided urine after prostatic massage from patients with prostate cancer: a pilot study.

Rehman I, Azzouzi AR, Catto JW, Allen S, Cross SS, Feeley K, Meuth M, Hamdy FC. Rehman I, et al. Among authors: catto jw. Urology. 2004 Dec;64(6):1238-43. doi: 10.1016/j.urology.2004.06.063. Urology. 2004. PMID: 15596215

8

Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions.

Rehman I, Azzouzi AR, Cross SS, Deloulme JC, Catto JW, Wylde N, Larre S, Champigneuille J, Hamdy FC. Rehman I, et al. Among authors: catto jw. Hum Pathol. 2004 Nov;35(11):1385-91. doi: 10.1016/j.humpath.2004.07.015. Hum Pathol. 2004. PMID: 15668896

9

Promoter hyper-methylation of calcium binding proteins S100A6 and S100A2 in human prostate cancer.

Rehman I, Cross SS, Catto JW, Leiblich A, Mukherjee A, Azzouzi AR, Leung HY, Hamdy FC. Rehman I, et al. Among authors: catto jw. Prostate. 2005 Dec 1;65(4):322-30. doi: 10.1002/pros.20302. Prostate. 2005. PMID: 16015609

10

Methylational urinalysis: a prospective study of bladder cancer patients and age stratified benign controls.

Yates DR, Rehman I, Meuth M, Cross SS, Hamdy FC, Catto JW. Yates DR, et al. Among authors: catto jw. Oncogene. 2006 Mar 23;25(13):1984-8. doi: 10.1038/sj.onc.1209209. Oncogene. 2006. PMID: 16288222

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

279 results

Search Page

Filters